MXPA02003270A - Peptido antigenico del virus de hepatitis e y metodos de elaboracion. - Google Patents

Peptido antigenico del virus de hepatitis e y metodos de elaboracion.

Info

Publication number: MXPA02003270A
Authority: MX; Mexico
Prior art keywords: methods; antigenic peptide; hev antigenic; novel hev; novel
Prior art date: 1999-09-30

Application number

MXPA02003270A

Other languages

English (en)

Inventor

Mun Hon Ng

Original Assignee

Yang Sheng Tang Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-30

Filing date

2000-09-28

Publication date

2003-08-20

2000-09-28 Application filed by Yang Sheng Tang Co Ltd filed Critical Yang Sheng Tang Co Ltd

2003-08-20 Publication of MXPA02003270A publication Critical patent/MXPA02003270A/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28111—Hepevirus, e.g. hepatitis E virus
- C12N2770/28122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Microbiology (AREA)
Public Health (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Cell Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Enzymes And Modification Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

MXPA02003270A 1999-09-30 2000-09-28 Peptido antigenico del virus de hepatitis e y metodos de elaboracion. MXPA02003270A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CA002283538A CA2283538A1 (en)	1999-09-30	1999-09-30	New hev antigenic peptide and methods
PCT/IB2000/001393 WO2001022916A2 (en)	1999-09-30	2000-09-28	Novel hev antigenic peptide and methods

Publications (1)

Publication Number	Publication Date
MXPA02003270A true MXPA02003270A (es)	2003-08-20

Family

ID=4164210

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA02003270A MXPA02003270A (es)	1999-09-30	2000-09-28	Peptido antigenico del virus de hepatitis e y metodos de elaboracion.

Country Status (11)

Country	Link
US (1)	US7204989B1 (es)
EP (1)	EP1461357B1 (es)
JP (1)	JP4641695B2 (es)
KR (1)	KR100743580B1 (es)
CN (1)	CN1195774C (es)
AU (1)	AU7308200A (es)
BR (1)	BRPI0014390C1 (es)
CA (1)	CA2283538A1 (es)
DE (1)	DE60042130D1 (es)
MX (1)	MXPA02003270A (es)
WO (1)	WO2001022916A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101367869B (zh)	2000-09-30	2012-12-05	北京万泰生物药业股份有限公司	用于预防、诊断及治疗戊型肝炎病毒的多肽,及它们作为诊断试剂和疫苗
EP1602928A1 (en) *	2004-06-01	2005-12-07	Universiteit Maastricht	Process and kit for determining binding parameters of bioaffinity binding reactions
CN1850855B (zh) *	2006-05-26	2012-08-29	厦门大学	用于免疫或制备单克隆抗体的方法和组合物
JP5869885B2 (ja) *	2009-02-27	2016-02-24	ザリージェンツオブザユニバーシティオブカリフォルニア	Ｅ型肝炎ウイルス様粒子を用いた多抗原送達系
US8906863B2 (en)	2009-02-27	2014-12-09	The Regents Of The University Of California	Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector
US8906862B2 (en)	2009-02-27	2014-12-09	The Regents Of The University Of California	Multiple antigen delivery system using hepatitis E virus-like particle
FR3044312B1 (fr) *	2015-11-30	2017-12-08	Biomerieux Sa	Polypeptides mutes de hev et leur utilisation pour le dosage d'anticorps anti-hev
CN112384530B (zh) *	2018-07-10	2024-02-06	国家医疗保健研究所	戊型肝炎病毒orf2i蛋白的表位肽
CN112724205B (zh) *	2021-02-01	2023-05-02	山西省中医药研究院（山西省中医院）	C种戊型肝炎病毒239蛋白制备病毒样颗粒的方法和应用
CN117730255A (zh) *	2021-07-06	2024-03-19	株式会社先端生命科学研究所	E型肝炎病毒感染的检测方法、e型肝炎病毒感染检测用抗原多肽和试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6455492B1 (en) *	1988-06-17	2002-09-24	Genelabs Technologies, Inc.	Hepatitis E virus vaccine and method
US6214970B1 (en) *	1988-06-17	2001-04-10	Genelabs Technologies, Inc.	Hepatitis E virus antigens and uses therefor
US5741490A (en) *	1988-06-17	1998-04-21	Genelabs Technologies, Inc.	Hepatitis E virus vaccine and method
US5686239A (en) *	1988-06-17	1997-11-11	Genelabs Technologies, Inc.	Hepatitis E virus peptides and methods
WO1995008632A1 (en) *	1993-09-24	1995-03-30	The Macfarlane Burnet Centre For Medical Research Limited	Immunoreactive antigens of hepatitis e virus

1999
- 1999-09-30 CA CA002283538A patent/CA2283538A1/en not_active Abandoned
2000
- 2000-09-28 AU AU73082/00A patent/AU7308200A/en not_active Abandoned
- 2000-09-28 WO PCT/IB2000/001393 patent/WO2001022916A2/en not_active Ceased
- 2000-09-28 BR BRPI0014390A patent/BRPI0014390C1/pt not_active IP Right Cessation
- 2000-09-28 JP JP2001526129A patent/JP4641695B2/ja not_active Expired - Lifetime
- 2000-09-28 EP EP00960932A patent/EP1461357B1/en not_active Expired - Lifetime
- 2000-09-28 CN CNB008135827A patent/CN1195774C/zh not_active Expired - Lifetime
- 2000-09-28 MX MXPA02003270A patent/MXPA02003270A/es active IP Right Grant
- 2000-09-28 US US10/089,292 patent/US7204989B1/en not_active Expired - Lifetime
- 2000-09-28 KR KR1020027004055A patent/KR100743580B1/ko not_active Expired - Lifetime
- 2000-09-28 DE DE60042130T patent/DE60042130D1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
BR0014390A (pt)	2003-09-30
BRPI0014390C1 (pt)	2021-08-10
DE60042130D1 (de)	2009-06-10
JP2004500041A (ja)	2004-01-08
KR20020065475A (ko)	2002-08-13
KR100743580B1 (ko)	2007-07-27
JP4641695B2 (ja)	2011-03-02
EP1461357A2 (en)	2004-09-29
HK1051544A1 (en)	2003-08-08
CN1391579A (zh)	2003-01-15
EP1461357B1 (en)	2009-04-29
EP1461357A4 (en)	2004-11-17
WO2001022916A3 (en)	2004-07-08
WO2001022916A2 (en)	2001-04-05
BRPI0014390B8 (pt)	2021-07-06
BRPI0014390B1 (pt)	2019-05-28
AU7308200A (en)	2001-04-30
US7204989B1 (en)	2007-04-17
CA2283538A1 (en)	2001-03-30
CN1195774C (zh)	2005-04-06

Publication	Publication Date	Title
PT1801219E (pt)	2015-12-30	Péptidos antigénicos de neisseria
HU230007B1 (en)	2015-04-28	Antigenic peptides derived from telomerase
ZA9811849B (en)	2000-06-23	Vaccine.
ZA984969B (en)	1999-12-09	Vaccine.
ZA988789B (en)	2000-03-29	Vaccine.
AU1951201A (en)	2001-06-12	Peptide antigens
HUP0102833A3 (en)	2002-03-28	Cyclosporins, process for preparation thereof and their use
AU6059699A (en)	2000-04-10	Synthetic peptides, conjugation reagents and methods
GB0128994D0 (en)	2002-01-23	Peptides
MXPA01010404A (es)	2003-07-21	Peptidos moduladores de adhesion y metodos para utilizarlos.
MXPA02003270A (es)	2003-08-20	Peptido antigenico del virus de hepatitis e y metodos de elaboracion.
GB0007933D0 (en)	2000-05-17	Assays,methods and means
GB9918155D0 (en)	1999-10-06	Proteins and peptides
EP1147130A4 (en)	2004-09-29	ALPHA-conotoxin PEPTIDE
GB9927681D0 (en)	2000-01-19	Protein
GB9929937D0 (en)	2000-02-09	Antigen delivery
GB2348701B (en)	2001-06-20	Assays,methods and means
GB0120713D0 (en)	2001-10-17	Peptides
GB9915419D0 (en)	1999-09-01	Antigens
GB9924060D0 (en)	1999-12-15	VIP54 protein
IL150134A0 (en)	2002-12-01	Apoptin-associating protein
GB9911692D0 (en)	1999-07-21	Antigenic combinations
GB9929923D0 (en)	2000-02-09	Antigen preparations
EP1188828A4 (en)	2002-11-06	REG-BINDING PROTEIN
AUPP899699A0 (en)	1999-03-25	Peptides, agents and methods

Legal Events

Date	Code	Title	Description
2008-03-11	FG	Grant or registration
2009-06-05	GB	Transfer or rights